IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP IV, LLC

Q1 2020 Holdings

Filed 2020-05-11 | 3 holdings | $109.4K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Magenta Therapeutics, Inc.COM55910K108$50.3K8,008,20446.0%
Revolution Medicines, Inc.(RVMD)COM76155X100$31.1K1,419,90028.4%
Fulcrum Therapeutics, Inc.(FULC)COM359616109$28.0K2,343,15425.6%